Scientists found a hidden Alzheimer’s trigger and shut it down
Researchers at Indiana University have identified an enzyme called IDOL as a potential target for Alzheimer's treatment. By removing IDOL from neurons, they observed a significant reduction in amyloid plaques and improvements in brain communication. This discovery may lead to new therapies that not only slow the disease but also enhance brain resilience.
- ▪The enzyme IDOL could become a major target in Alzheimer's disease treatment.
- ▪Removing IDOL from neurons significantly reduced amyloid plaques and improved brain processes.
- ▪Targeting IDOL may provide a new strategy for treating Alzheimer's while enhancing communication between brain cells.
ScienceDaily files mainly under science. We currently carry 88 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | ScienceDaily |
| Canonical URL | https://www.sciencedaily.com/releases/2026/05/260519224334.htm |
| Publication time | Wed, 20 May 2026 08:54:32 EDT |
| Retrieval time | 2026-05-20T13:10:02.546Z |
| Last seen | 2026-05-20T13:10:02.546Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | ajCc5Eh6WaQ7 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Science News from research organizations Scientists found a hidden Alzheimer’s trigger and shut it down Date: May 20, 2026 Source: Indiana University Summary: A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyloid plaques and improved key brain processes linked to resilience and communication between cells. The discovery may lead to future treatments that go beyond slowing Alzheimer’s — potentially helping protect the brain from further decline. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY Scientists may have found a powerful new Alzheimer’s drug target that not only clears brain plaques but could also help the brain fight back.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at ScienceDaily.
Discussion
0 commentsMore from ScienceDaily
